GlobalData on MSN2d
Glooko integrates Abbott’s FreeStyle Libre onto platform
Users of Abbott’s CGM device can now view data and gain additional insights through Glooko’s diabetes management platform.
Fierce Biotech7d
Insulet Type 1 diabetes study shows gains in 3 months after starting first automated insulin pump
A randomized study from Insulet of adults and children with Type 1 diabetes found that moving from multiple daily injections ...
Drug Delivery Business3d
Glooko integrates diabetes management platform with Abbott FreeStyle Libre
Glooko announced today that its platform now supports the Abbott FreeStyle Libre continuous glucose monitoring (CGM) in the U ...
Abbott Stock Could Be On The Verge Of A Breakout - Here's What Smart Money Sees
Abbott Laboratories is undervalued with strong growth in diabetes care and weight-loss markets. Discover why ABT stock is a ...
Drug Delivery Business7d
Insulet study shows improvements with Omnipod 5 transitioning from multiple daily injections
Participants began with an average HbA1c level of 8.1%. After three months, people who used Omnipod 5 improved HbA1c by an ...
Sequel Announces First CGM Integration for its twiist AID System: Abbott's FreeStyle Libre 3 Plus Sensor
We are thrilled to announce our collaboration with Abbott, integrating its world-leading FreeStyle Libre technology 2 as our first CGM partner, marking a significant milestone as we bring our ...
Physician's Weekly15d
Continuous Glucose Monitoring and Glycemic Control After Discharge
The following is a summary of “Randomized Study Comparing Continuous Glucose Monitoring and Capillary Glucose Testing in ...
Yahoo Finance2d
Glooko integrates Abbott’s FreeStyle Libre onto platform
Abbott’s continuous glucose monitoring (CGM) device, the FreeStyle Libre, has been integrated with Glooko’s digital platform for diabetes management. The integration is available for ...